Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions.

Morikawa LK, Roach M 3rd.

Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):6-16. doi: 10.1016/j.ijrobp.2010.11.074. Review.

PMID:
21481721
2.

Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer.

Galalae RM, Kovács G, Schultze J, Loch T, Rzehak P, Wilhelm R, Bertermann H, Buschbeck B, Kohr P, Kimmig B.

Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):81-90.

PMID:
11777625
3.
4.
5.

Nodal Clearance Rate and Long-Term Efficacy of Individualized Sentinel Node-Based Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate Cancer.

Müller AC, Eckert F, Paulsen F, Zips D, Stenzl A, Schilling D, Alber M, Bares R, Martus P, Weckermann D, Belka C, Ganswindt U.

Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):263-71. doi: 10.1016/j.ijrobp.2015.10.031. Epub 2015 Dec 10.

PMID:
26853335
6.

Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy.

Mantini G, Tagliaferri L, Mattiucci GC, Balducci M, Frascino V, Dinapoli N, Di Gesù C, Ippolito E, Morganti AG, Cellini N.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e721-6. doi: 10.1016/j.ijrobp.2010.12.003. Epub 2011 Jan 27.

PMID:
21277100
7.

Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.

Martinez AA, Demanes DJ, Galalae R, Vargas C, Bertermann H, Rodriguez R, Gustafson G, Altieri G, Gonzalez J.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1322-31.

PMID:
16029788
8.

Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation.

Vargas CE, Galalae R, Demanes J, Harsolia A, Meldolesi E, Nürnberg N, Schour L, Martinez A.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1474-82. Epub 2005 Jun 20.

PMID:
15964706
9.

Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement.

Jacob R, Hanlon AL, Horwitz EM, Movsas B, Uzzo RG, Pollack A.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):695-701.

PMID:
15708247
10.

A systematic overview of radiation therapy effects in prostate cancer.

Nilsson S, Norlén BJ, Widmark A.

Acta Oncol. 2004;43(4):316-81. Review.

PMID:
15303499
11.
12.

Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.

Lim TS, Cheung PC, Loblaw DA, Morton G, Sixel KE, Pang G, Basran P, Zhang L, Tirona R, Szumacher E, Danjoux C, Choo R, Thomas G.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):85-92. doi: 10.1016/j.ijrobp.2007.12.041. Epub 2008 Mar 20.

PMID:
18355982
13.

Whole-pelvic nodal radiation therapy in the context of hypofractionation for high-risk prostate cancer patients: a step forward.

Kaidar-Person O, Roach M 3rd, Créhange G.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):600-5. doi: 10.1016/j.ijrobp.2013.02.006. Epub 2013 Mar 20. Review.

PMID:
23523182
15.

Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: evidence, rationale, and future directions: in regard to Morikawa and Roach III (Int J Radiat Oncol Biol Phys 2011 May 1;80:6-16).

Revannasiddaiah S, Gupta MK, Seam RK, Madabhavi I.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1318; author reply 1318. doi: 10.1016/j.ijrobp.2011.11.061. No abstract available.

PMID:
22385711
17.

Phase II trial of radiation dose escalation with conformal external beam radiotherapy and high-dose-rate brachytherapy combined with long-term androgen suppression in unfavorable prostate cancer: feasibility report.

Valero J, Cambeiro M, Galán C, Teijeira M, Romero P, Zudaire J, Moreno M, Ciérvide R, Aristu JJ, Martínez-Monge R.

Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):386-92. doi: 10.1016/j.ijrobp.2009.01.059. Epub 2009 May 8.

PMID:
19427741
18.

Technological advances in radiotherapy for the treatment of localised prostate cancer.

Mangar SA, Huddart RA, Parker CC, Dearnaley DP, Khoo VS, Horwich A.

Eur J Cancer. 2005 Apr;41(6):908-21. Review.

PMID:
15808957
19.

High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.

Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, Reuter VE, Venkatraman ES, Leibel SA.

J Urol. 2001 Sep;166(3):876-81. Erratum in: J Urol 2001 Nov;166(5):1839.

PMID:
11490237
20.

Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.

Martinez AA, Kestin LL, Stromberg JS, Gonzalez JA, Wallace M, Gustafson GS, Edmundson GK, Spencer W, Vicini FA.

Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):343-52.

PMID:
10802358

Supplemental Content

Support Center